Year archive

Vivoryon Therapeutics N.V. — 2015 filings

All 35 regulatory filings released by Vivoryon Therapeutics N.V. (VVY) in 2015, sourced directly from the official regulator.

35 Filings

2015 Period

2015 filings (35)

Filing	Released	Lang
Probiodrug announces publication of initial PQ912 clinical data demonstrating inhibition of glutaminyl cyclase Earnings Release Q4 2015	2015-12-15	English
Probiodrug AG: Release of the Home Member State according to Article 2c of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Regulatory Filings	2015-11-30	English
Probiodrug AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Declaration of Voting Results & Voting Rights Announcements	2015-11-30	English
Probiodrug reports Third Quarter 2015 Business Update Interim / Quarterly Report Q3 2015	2015-11-19	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-11-17	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-11-13	English
Report Publication Announcement 2015 Report Publication Announcement	2015-11-12	English
Probiodrug presented data on its pGlu-3 Abeta monoclonal Antibody at Neuroscience 2015, Chicago Earnings Release FY 2015	2015-10-19	English
Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany Regulatory Filings	2015-10-12	English
Probiodrug reports financial results for H1 2015 Interim / Quarterly Report H1 2015	2015-08-27	English
Probiodrug AG to Publish First Half 2015 Results on 27 August, 2015 Report Publication Announcement	2015-08-20	English
Report Publication Announcement 2015 Report Publication Announcement	2015-08-20	English
Probiodrug to present at Canaccord Genuity 35th Annual Growth Conference in Boston Investor Presentation	2015-08-10	English
Probiodrug: Annual General Meeting and Election of New Supervisory Board members AGM Information	2015-06-10	English
Probiodrug to present at the Jefferies Healthcare Conference and BIO International Convention Regulatory Filings	2015-05-29	English
Probiodrug to present at Bio€quity Europe 2015 in Vienna Regulatory Filings	2015-05-18	English
Probiodrug reports First Quarter 2015 Business Update Interim / Quarterly Report Q1 2015	2015-05-13	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-05-11	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-05-08	English
Probiodrug to hold its Annual Shareholders Meeting on June 10, 2015 AGM Information	2015-05-08	English
Probiodrug AG to publish its First Quarter 2015 Business Update on May 13, 2015 Report Publication Announcement	2015-05-06	English
Report Publication Announcement 2015 Report Publication Announcement	2015-05-06	English
Probiodrug to Present at Drug Design & Medicinal Chemistry Conference 2015 Regulatory Filings	2015-05-05	English
Probiodrug AG: Bekanntmachung der Einberufung zur Hauptversammlung am 10.06.2015 in Berlin mit dem Ziel der europaweiten Verbreitung gema 121 AktG AGM Information	2015-04-28	German
Probiodrug: Key patents on Glutaminyl Cyclase (QC) inhibition for the treatment of Alzheimer's disease granted in Japan Regulatory Filings	2015-04-23	English
Probiodrug reports full year 2014 financial results Earnings Release FY 2014	2015-03-31	English
Probiodrug to present at Conference on Alzheimer's and Parkinson's Diseases (AD/PDTM 2015) Regulatory Filings	2015-03-20	English
Report Publication Announcement 2015 Report Publication Announcement	2015-03-18	English
Probiodrug AG to publish its 2014 Annual Report on March 31, 2015 Report Publication Announcement	2015-03-18	English
Probiodrug announces enrolment of first patient in Phase 2 Study of novel Treatment for Alzheimer's disease Regulatory Filings	2015-03-09	English
Probiodrug: Data on Glutaminyl Cyclases (QCs) in its relation to Alzheimer's Disease (AD) published in Acta Neuropathologica Regulatory Filings	2015-03-03	English
Probiodrug to present at European Life Sciences Conferences Regulatory Filings	2015-02-25	English
Probiodrug to Present at Drug Discovery USA 2015 Regulatory Filings	2015-02-09	English
Probiodrug to present at 17th Annual BIO CEO & Investor Conference, New York City Regulatory Filings	2015-02-04	English
Declaration of Voting Results & Voting Rights Announcements 2015 Declaration of Voting Results & Voting Rights Announcements	2015-01-13	English

Filings by year

2026 7 filings
2025 24 filings
2024 22 filings
2023 27 filings
2022 45 filings
2021 43 filings
2020 47 filings
2019 54 filings
2018 28 filings
2017 25 filings
2016 33 filings
2015 35 filings
2014 10 filings